No black box warning on record for Egrifta Sv
As of the latest FDA labeling reviewed, Egrifta Sv (TESAMORELIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Egrifta Sv medicine page for the complete safety profile.